Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs052260189Recruiting
Randomised, open-label trial of seasonal influenza hemagglutinin vaccine in seasonal influenza (2 arms), sponsored by Daicel Medical. Primary endpoint: Immunogenicity at Day 22. Started Oct 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs052260189.